340B Transparency Act

HR 3290, the 340B Transparency Act, requires safety-net hospitals and clinics participating in the 340B drug discount program to report detailed data about their drug usage and patient demographics to the Department of Health and Human Services (HHS). Covered entities must track and report the number of patients receiving 340B drugs by insurance type (like Medicaid or private insurance), costs for charity care, and savings from discounted drugs. HHS will publish this data annually on a public website in an easily searchable format. The bill adds new reporting requirements for entities to demonstrate how they use savings from the 340B program and allows HHS to audit their records to ensure compliance.